Could a common gout drug soothe inflamed arteries in diabetes patients?
NCT ID NCT04181996
First seen May 07, 2026 · Last updated May 24, 2026 · Updated 3 times
Summary
This study tested whether colchicine, an anti-inflammatory drug, can reduce inflammation in the arteries of people with diabetes or pre-diabetes who recently had a heart attack or stroke. 115 participants received colchicine or placebo, and researchers used PET scans to measure changes in artery inflammation over 6 months. The goal was to see if targeting inflammation could help prevent future cardiovascular events.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mazankowski Alberta Heart Institute
Edmonton, Alberta, T6G 2B7, Canada
-
University of Ottawa Heart Institute
Ottawa, Ontario, K1Y 4W7, Canada
Conditions
Explore the condition pages connected to this study.